White Matter Microstructure in Bipolar Disorder Is Influenced by the Interaction between a Glutamate Transporter EAAT1 Gene Variant and Early Stress.


Journal

Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 04 12 2017
accepted: 11 05 2018
pubmed: 24 5 2018
medline: 2 4 2019
entrez: 24 5 2018
Statut: ppublish

Résumé

Glutamate is the principal excitatory neurotransmitter in the central nervous system. In mature brains, it is critically involved in neuroplasticity and, at high levels, neurotoxicity. The concentrations of glutamate in the extracellular space are maintained at low physiological levels by molecular glutamate transporters (excitatory amino acid transporters-EAATs). Adverse childhood experiences (ACEs) are highly reported in bipolar disorder (BD) and interact with the glutamatergic system in the brain. The aim of the study is to investigate the effect of a glutamate transporter polymorphism EAAT2-181A > C (rs4354668) and exposure to ACE on white matter microstructure in patients with BD. We assessed 175 bipolar subjects using diffusion tensor imaging, Risky Families Questionnaire, and EEAT2 rs4354668 variants. We observed an interaction between ACE and rs4354668: carriers of the G allele showed lower axial diffusivity compared to T/T homozygotes when exposed to high stress and higher axial diffusivity than T/T when exposed to low stress. Since the mutant G allele has been associated with a reduced transcriptional activity and expression of the transporter protein, and early stress is associated with a reduced expression of the EAAT2, we could hypothesize that after exposure to high levels of ACE G/G homozygotes are more vulnerable to stress reporting the highest damage as a consequence of an excess of free glutamate.

Identifiants

pubmed: 29790085
doi: 10.1007/s12035-018-1117-6
pii: 10.1007/s12035-018-1117-6
doi:

Substances chimiques

Excitatory Amino Acid Transporter 1 0
SLC1A3 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

702-710

Subventions

Organisme : Ministero della Salute
ID : RF-2011-02350980
Organisme : FP7 Health
ID : 222963

Références

Environ Res. 1999 May;80(4):348-54
pubmed: 10330308
J Neurosci. 1999 Jul 15;19(14):RC16
pubmed: 10407058
Nat Med. 2000 Jan;6(1):67-70
pubmed: 10613826
AJNR Am J Neuroradiol. 2000 May;21(5):832-8
pubmed: 10815657
Mol Psychiatry. 2000 Nov;5(6):578-93
pubmed: 11126389
Brain Res Mol Brain Res. 2000 Dec 28;85(1-2):24-31
pubmed: 11146103
Trends Neurosci. 2001 Apr;24(4):224-30
pubmed: 11250007
Prog Neurobiol. 2001 Sep;65(1):1-105
pubmed: 11369436
Am J Psychiatry. 2001 Sep;158(9):1393-9
pubmed: 11532723
Hum Brain Mapp. 2002 Jan;15(1):1-25
pubmed: 11747097
Mol Psychiatry. 2002;7 Suppl 1:S71-80
pubmed: 11986998
Bipolar Disord. 2002 Dec;4(6):357-65
pubmed: 12519095
Ann N Y Acad Sci. 2003 May;993:229-75; discussion 287-8
pubmed: 12853317
Neurology. 2003 Oct 28;61(8):1113-20
pubmed: 14581674
Psychopharmacology (Berl). 2004 Apr;173(1-2):227-8
pubmed: 14722708
Schizophr Res. 2004 Apr 1;67(2-3):269-75
pubmed: 14984887
Arch Gen Psychiatry. 2004 May;61(5):450-8
pubmed: 15123489
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
J Pers. 2004 Dec;72(6):1365-93
pubmed: 15509286
Biol Psychiatry. 2005 Feb 15;57(4):430-2
pubmed: 15705360
Glia. 2005 Oct;52(1):36-46
pubmed: 15892126
Eur Neuropsychopharmacol. 2006 Jan;16(1):71-7
pubmed: 16023835
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15653-8
pubmed: 16230605
Nature. 2005 Dec 22;438(7071):1162-6
pubmed: 16372011
Nature. 2005 Dec 22;438(7071):1167-71
pubmed: 16372012
Biol Psychiatry. 2006 Aug 1;60(3):296-301
pubmed: 16460697
J Exp Med. 2006 Mar 20;203(3):711-7
pubmed: 16520390
Neuroimage. 2007 Apr 1;35(2):478-87
pubmed: 17292629
J Immunol. 2007 May 15;178(10):6549-56
pubmed: 17475885
J Anat. 2007 Jun;210(6):693-702
pubmed: 17504270
CNS Neurol Disord Drug Targets. 2007 Jun;6(3):219-33
pubmed: 17511618
Nat Neurosci. 2007 Sep;10(9):1103-9
pubmed: 17726476
J Neurosci. 2008 Feb 6;28(6):1479-89
pubmed: 18256269
J Neuroimmunol. 2008 Mar;195(1-2):194-8
pubmed: 18378006
Brain Res. 2008 May 19;1210:11-9
pubmed: 18410911
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Neuroscience. 2008 Sep 9;155(4):1204-11
pubmed: 18620031
Neuroimage. 2009 Mar;45(1 Suppl):S173-86
pubmed: 19059349
J Neurochem. 2009 Mar;108(6):1385-98
pubmed: 19183259
Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):316-28
pubmed: 19255710
J Alzheimers Dis. 2009;16(3):649-56
pubmed: 19276559
Br J Psychiatry. 2009 Jun;194(6):527-34
pubmed: 19478293
Psychiatry Res. 2009 Sep 30;173(3):238-42
pubmed: 19682864
Schizophr Res. 2010 Mar;117(1):92-8
pubmed: 19716271
Neuropharmacology. 2010 Feb;58(2):465-73
pubmed: 19747495
Neurosci Lett. 2010 Jan 18;469(1):75-80
pubmed: 19932153
Gastroenterology. 2010 Jun;138(7):2418-25
pubmed: 20226190
Am J Psychiatry. 2010 May;167(5):509-27
pubmed: 20231323
Mol Psychiatry. 2011 Jun;16(6):634-46
pubmed: 20386568
Psychol Med. 2011 Mar;41(3):509-19
pubmed: 20529416
J Affect Disord. 2010 Dec;127(1-3):230-40
pubmed: 20580095
Biol Psychiatry. 2010 Sep 15;68(6):560-7
pubmed: 20598288
J Clin Psychiatry. 2010 Sep;71(9):1176-86; quiz 1252-3
pubmed: 20923622
Biol Psychiatry. 2011 Feb 15;69(4):309-17
pubmed: 20926068
Biol Psychiatry. 2011 Mar 15;69(6):513-9
pubmed: 21047622
J Anat. 2011 Jul;219(1):53-64
pubmed: 21250988
Glia. 2011 Apr;59(4):540-53
pubmed: 21319221
Neurosci Lett. 2011 Apr 20;494(1):54-6
pubmed: 21362460
J Cell Physiol. 2011 Oct;226(10):2484-93
pubmed: 21792905
J Affect Disord. 2012 Jan;136(1-2):63-71
pubmed: 21925739
Cereb Cortex. 2012 Sep;22(9):1979-92
pubmed: 22002939
Bipolar Disord. 2011 Nov-Dec;13(7-8):604-13
pubmed: 22085473
Nat Rev Neurosci. 2011 Nov 30;13(1):22-37
pubmed: 22127301
Neuropharmacology. 2012 Apr;62(5-6):1944-53
pubmed: 22245561
Biol Psychiatry. 2013 Jan 1;73(1):85-92
pubmed: 22770651
Bipolar Disord. 2012 Sep;14(6):597-606
pubmed: 22882719
Neuropsychopharmacology. 2013 Jan;38(2):313-27
pubmed: 22990942
Biol Psychiatry. 2013 Aug 15;74(4):280-6
pubmed: 23453289
Neuropsychologia. 2013 Jul;51(8):1435-44
pubmed: 23507612
J Psychiatr Res. 2013 Sep;47(9):1150-6
pubmed: 23706640
J Affect Disord. 2014 Feb;155:223-33
pubmed: 24295601
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jun 3;51:146-52
pubmed: 24518437
Psychol Med. 2014 Oct;44(14):3069-82
pubmed: 25065766
Bipolar Disord. 2014 Dec;16(8):857-66
pubmed: 25219494
Harv Rev Psychiatry. 2014 Nov-Dec;22(6):334-7
pubmed: 25377605
J Affect Disord. 2015 Mar 15;174:233-40
pubmed: 25527993
J Affect Disord. 2015 Mar 15;174:342-52
pubmed: 25553397
Curr Psychiatry Rep. 2015 Feb;17(2):8
pubmed: 25620790
Neurosci Lett. 1989 Aug 28;103(2):162-8
pubmed: 2570387
Neuropharmacology. 2015 Dec;99:168-76
pubmed: 26187394
J Affect Disord. 2016 Jan 1;189:290-7
pubmed: 26454335
Psychol Med. 2016 May;46(7):1547-58
pubmed: 26947335
J Affect Disord. 2016 Sep 15;202:1-9
pubmed: 27253210
Psychiatry Res. 2016 Oct 30;244:19-23
pubmed: 27455146
Mol Neuropsychiatry. 2017 Feb;2(4):185-197
pubmed: 28277565
Neurosci Lett. 2017 Aug 24;656:177-181
pubmed: 28754344
Am J Psychiatry. 1993 Nov;150(11):1731-3
pubmed: 8214185
Neuron. 1996 Mar;16(3):675-86
pubmed: 8785064
Neuroreport. 1997 Feb 10;8(3):775-7
pubmed: 9106765
Brain Res Mol Brain Res. 1998 May;56(1-2):207-17
pubmed: 9602129
Am J Prev Med. 1998 May;14(4):245-58
pubmed: 9635069

Auteurs

Sara Poletti (S)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy. poletti.sara@hsr.it.

Irene Bollettini (I)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Cristina Lorenzi (C)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Alice Vitali (A)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Silvia Brioschi (S)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Alessandro Serretti (A)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

Cristina Colombo (C)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Francesco Benedetti (F)

Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH